Ishioka G - Search Results

1

DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles.

Sidney J, Oseroff C, Southwood S, Wall M, Ishioka G, Koning F, Sette A. Sidney J, et al. Among authors: ishioka g. J Immunol. 1992 Oct 15;149(8):2634-40. J Immunol. 1992. PMID: 1401902

2

MHC interaction and T cell recognition of carbohydrates and glycopeptides.

Ishioka GY, Lamont AG, Thomson D, Bulbow N, Gaeta FC, Sette A, Grey HM. Ishioka GY, et al. J Immunol. 1992 Apr 15;148(8):2446-51. J Immunol. 1992. PMID: 1560200

3

T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis.

Franco A, Southwood S, Arrhenius T, Kuchroo VK, Grey HM, Sette A, Ishioka GY. Franco A, et al. Among authors: ishioka gy. Eur J Immunol. 1994 Apr;24(4):940-6. doi: 10.1002/eji.1830240424. Eur J Immunol. 1994. PMID: 7512036

4

Definition of a DQ3.1-specific binding motif.

Sidney J, Oseroff C, del Guercio MF, Southwood S, Krieger JI, Ishioka GY, Sakaguchi K, Appella E, Sette A. Sidney J, et al. Among authors: ishioka gy. J Immunol. 1994 May 1;152(9):4516-25. J Immunol. 1994. PMID: 7512598

5

Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides.

Ishioka GY, Adorini L, Guery JC, Gaeta FC, LaFond R, Alexander J, Powell MF, Sette A, Grey HM. Ishioka GY, et al. J Immunol. 1994 May 1;152(9):4310-9. J Immunol. 1994. PMID: 8157954

6

Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.

Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, del Guercio MF, Oseroff C, Dahlberg C, Alexander J, Chesnut RW, Sette A. Ishioka GY, et al. J Immunol. 1999 Apr 1;162(7):3915-25. J Immunol. 1999. PMID: 10201910

7

A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery.

Alexander J, Oseroff C, Dahlberg C, Qin M, Ishioka G, Beebe M, Fikes J, Newman M, Chesnut RW, Morton PA, Fok K, Appella E, Sette A. Alexander J, et al. Among authors: ishioka g. J Immunol. 2002 Jun 15;168(12):6189-98. doi: 10.4049/jimmunol.168.12.6189. J Immunol. 2002. PMID: 12055232

8

Improved immunogenicity of an immunodominant epitope of the HER-2/neu protooncogene by alterations of MHC contact residues.

Vertuani S, Sette A, Sidney J, Southwood S, Fikes J, Keogh E, Lindencrona JA, Ishioka G, Levitskaya J, Kiessling R. Vertuani S, et al. Among authors: ishioka g. J Immunol. 2004 Mar 15;172(6):3501-8. doi: 10.4049/jimmunol.172.6.3501. J Immunol. 2004. PMID: 15004150

9

Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus.

Alexander J, Bilsel P, del Guercio MF, Marinkovic-Petrovic A, Southwood S, Stewart S, Ishioka G, Kotturi MF, Botten J, Sidney J, Newman M, Sette A. Alexander J, et al. Among authors: ishioka g. Hum Immunol. 2010 May;71(5):468-74. doi: 10.1016/j.humimm.2010.02.014. Epub 2010 Mar 10. Hum Immunol. 2010. PMID: 20156506 Free PMC article.

10

Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide.

Tangri S, Ishioka GY, Huang X, Sidney J, Southwood S, Fikes J, Sette A. Tangri S, et al. Among authors: ishioka gy. J Exp Med. 2001 Sep 17;194(6):833-46. doi: 10.1084/jem.194.6.833. J Exp Med. 2001. PMID: 11560998 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters